Enzon Pharmaceuticals, Inc. Presents New Data on Its LNA Programs
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) presented data from its LNA technology platform at the 4th Annual Meeting of Oligonucleotide Therapeutics Society (OTS) in Boston, Massachusetts.